Pauline Richards
Pauline Richards's purchase track record
Pauline Richards has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/12/2025 | APO | $78K | -0.6% | -8.1% | +16.9% |
| 8/6/2024 | APO | $247K | +44.9% | +58.3% | +15.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Apollo's EasyJet Deal Faces Union Pushback; Economist Warns of Stagflation. Apollo Global Management is navigating significant operational and macroeconomic headwinds. The proposed acquisition of EasyJet is facing opposition from European labor unions, with the deal expected to close before Q1 2027. Additionally, Apollo’s chief economist has described recent price data as a sign of stagflation, complicating the economic outlook. These developments add uncertainty to the firm's growth strategy and broader market positioning.
Transaction History
| WH | ▲ Buy | Grant | 463 | $34K | 7/24/2026 | View on chart |
| WH | ▲ Buy | Grant | 373 | $27K | 7/24/2026 | View on chart |
| WH | ▲ Buy | Grant | 421 | $34K | 5/1/2026 | View on chart |
| WH | ▲ Buy | Grant | 338 | $27K | 5/1/2026 | View on chart |
| WH | ▲ Buy | Grant | 326 | $0 | 3/10/2026 | View on chart |
| WH | ▲ Buy | Grant | 1,639 | $0 | 3/9/2026 | View on chart |
| WH | ▲ Buy | Grant | 300 | $0 | 3/3/2026 | View on chart |
| WH | ▲ Buy | Grant | 850 | $0 | 3/1/2026 | View on chart |
| WH | ▲ Buy | Grant | 404 | $34K | 2/20/2026 | View on chart |
| WH | ▲ Buy | Grant | 300 | $25K | 2/20/2026 | View on chart |
| WH | ▲ Buy | Grant | 455 | $34K | 10/24/2025 | View on chart |
| WH | ▲ Buy | Grant | 337 | $25K | 10/24/2025 | View on chart |
| WH | ▲ Buy | Grant | 370 | $34K | 7/25/2025 | View on chart |
| WH | ▲ Buy | Grant | 273 | $25K | 7/25/2025 | View on chart |
| APO | ▲ Buy | Grant | 1,446 | $0 | 7/1/2025 | View on chart |
| APO | ▲ Buy | Open Market | 550 | $78K | 5/12/2025 | View on chart |
| WH | ▲ Buy | Grant | 391 | $34K | 5/2/2025 | View on chart |
| WH | ▲ Buy | Grant | 287 | $25K | 5/2/2025 | View on chart |
| WH | ▲ Buy | Grant | 316 | $0 | 3/10/2025 | View on chart |
| WH | ▲ Buy | Grant | 1,176 | $0 | 3/3/2025 | View on chart |
| WH | ▲ Buy | Grant | 828 | $0 | 3/1/2025 | View on chart |
| WH | ▲ Buy | Grant | 402 | $0 | 2/27/2025 | View on chart |
| WH | ▲ Buy | Grant | 311 | $34K | 2/14/2025 | View on chart |
| WH | ▲ Buy | Grant | 49 | $5K | 2/14/2025 | View on chart |
| WH | ▲ Buy | Grant | 277 | $0 | 10/25/2024 | View on chart |
| WH | ▲ Buy | Grant | 375 | $34K | 10/25/2024 | View on chart |
| APO | ▲ Buy | Open Market | 2,351 | $247K | 8/6/2024 | View on chart |
| WH | ▲ Buy | Grant | 444 | $34K | 7/26/2024 | View on chart |
| WH | ▲ Buy | Grant | 300 | $0 | 7/26/2024 | View on chart |
| APO | ▲ Buy | Grant | 1,699 | $0 | 7/1/2024 | View on chart |
| WH | ▲ Buy | Grant | 456 | $34K | 4/26/2024 | View on chart |
| WH | ▲ Buy | Grant | 289 | $0 | 4/26/2024 | View on chart |
| WH | ▲ Buy | Grant | 312 | $0 | 3/10/2024 | View on chart |
| WH | ▲ Buy | Grant | 412 | $0 | 3/1/2024 | View on chart |
| WH | ▲ Buy | Grant | 1,632 | $0 | 2/29/2024 | View on chart |
| WH | ▲ Buy | Grant | 893 | $0 | 2/27/2024 | View on chart |
| WH | ▲ Buy | Grant | 245 | $0 | 2/16/2024 | View on chart |
| WH | ▲ Buy | Grant | 438 | $34K | 2/16/2024 | View on chart |
| WH | ▲ Buy | Grant | 480 | $34K | 10/27/2023 | View on chart |
| WH | ▲ Buy | Grant | 282 | $0 | 10/27/2023 | View on chart |
| APO | ▲ Buy | Grant | 2,444 | $0 | 8/4/2023 | View on chart |
| WH | ▲ Buy | Grant | 436 | $34K | 7/28/2023 | View on chart |
| WH | ▲ Buy | Grant | 299 | $0 | 7/28/2023 | View on chart |
| WH | ▲ Buy | Grant | 499 | $34K | 4/28/2023 | View on chart |
| WH | ▲ Buy | Grant | 287 | $0 | 4/28/2023 | View on chart |
| WH | ▲ Buy | Grant | 307 | $0 | 3/10/2023 | View on chart |
| WH | ▲ Buy | Grant | 1,617 | $0 | 3/1/2023 | View on chart |
| WH | ▲ Buy | Grant | 1,379 | $0 | 2/27/2023 | View on chart |
| WH | ▲ Buy | Grant | 247 | $0 | 2/17/2023 | View on chart |
| WH | ▲ Buy | Grant | 440 | $34K | 2/17/2023 | View on chart |
| WH | ▲ Buy | Grant | 456 | $34K | 10/27/2022 | View on chart |
| WH | ▲ Buy | Grant | 266 | $0 | 10/27/2022 | View on chart |
| APO | ▲ Buy | Grant | 3,617 | $0 | 8/2/2022 | View on chart |
| WH | ▲ Buy | Grant | 495 | $34K | 7/28/2022 | View on chart |
| WH | ▲ Buy | Grant | 260 | $0 | 7/28/2022 | View on chart |
| WH | ▲ Buy | Grant | 639 | $0 | 6/1/2022 | View on chart |
| WH | ▲ Buy | Grant | 375 | $34K | 4/28/2022 | View on chart |
| WH | ▲ Buy | Grant | 170 | $0 | 4/28/2022 | View on chart |
| WH | ▲ Buy | Grant | 1,208 | $0 | 3/10/2022 | View on chart |
| WH | ▲ Buy | Grant | 1,352 | $0 | 2/27/2022 | View on chart |
| WH | ▲ Buy | Grant | 389 | $34K | 2/17/2022 | View on chart |
| WH | ▲ Buy | Grant | 207 | $0 | 2/17/2022 | View on chart |
| APO | ▲ Buy | Grant | 75,743 | — | 1/1/2022 | View on chart |
| WH | ▲ Buy | Grant | 155 | $0 | 10/29/2021 | View on chart |
| WH | ▲ Buy | Grant | 403 | $34K | 10/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Wyndham Q3 Earnings Preview and Morgan Stanley Price Target Raise
Wyndham Hotels is preparing for its Q3 earnings report, which analysts expect to show a decline in results. Meanwhile, Morgan Stanley raised its price target for the stock to $92 while maintaining an Overweight rating. The company is also mentioned in industry discussions regarding soft brand conversions for hotel owners.
Wyndham Q3 Earnings Preview and Morgan Stanley Price Target Raise. Wyndham Hotels is preparing for its Q3 earnings report, which analysts expect to show a decline in results. Meanwhile, Morgan Stanley raised its price target for the stock to $92 while maintaining an Overweight rating. The company is also mentioned in industry discussions regarding soft brand conversions for hotel owners.